Wednesday, 16 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14398
Articles
Company
Deals
I-Mab and MorphoSys License Drugs to HIBio in Global Oncology Deal
February 27, 2025
Company
Deals
Adicon Holdings and Guardant Health Partner on Genomic Profiling in China
February 27, 2025
Company
Deals
BeiGene and InnoRNA Partner on mRNA-LNP Therapeutic Development
February 27, 2025
Company
Deals
PackGene and SineuGene Partner on ALS Gene Therapy Research
February 27, 2025
Policy / Regulatory
China Establishes Leadership Group to Combat Drug-Related Crimes
February 27, 2025
Company
Deals
Phil Rivers Tech Raises RMB 100 Million for Computational Medicine Push
February 27, 2025
Company
Drug
Gan & Lee Pharmaceuticals Doses First Patient in GZR101 Phase I Study
February 27, 2025
Company
Drug
Fosun Pharma’s FS-1502 Gets NMPA Approval for Gastric Cancer Study
March 2, 2025
Company
Drug
GeneScience’s Somatropin Wins NMPA Approval for Prader-Willi Syndrome
March 2, 2025
Company
Drug
Inmagene and HutchMed Dose First Patient in IMG-007 Global Phase I Study
March 2, 2025
Company
Deals
ClinChoice Raises USD 150M in Funding Led by Legend Capital for Expansion
March 2, 2025
Drug
InnoCare Pharma’s BCL2 Inhibitor ICP-248 Accepted for NMPA Review
March 2, 2025
1
2
…
1,178
1,179
1,180
1,181
1,182
…
1,199
1,200
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?